Anx Bio: Shareholder Ma Huaxiang plans to reduce holdings by no more than 0.94%.

Announcement from Anxu Biotech: Ma Huaxiang holds 14,773,400 shares, accounting for 11.62% of the total share capital. He plans to reduce his holdings by no more than 1,200,000 shares through centralized bidding within 3 months after the disclosure date of this announcement, not exceeding 0.94% of the total share capital, and reducing by no more than 1.00% within any consecutive 90 natural days.